Therapeutic agent for cartilaginous diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6756358
APP PUB NO 20020009432A1
SERIAL NO

09921874

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a therapeutic agent for cartilaginous diseases, an accelerator for chondrocyte proliferation and an accelerator for proteoglycan production comprising HGF (hepatocyte growth factor) as an active component, and a treatment method for cartilaginous diseases of human or mammals comprising administering an effective amount of HGF. The active component HGF has an effect to promote the proliferation of chondrocytes and to promote the production of proteoglycan. Therefore, the therapeutic agent and accelerator of the present invention are useful for the prevention and treatment of various disorders caused by cartilaginous diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TOSHIKAZU NAKAMURA1-4 HOSHOJICHO OKAZAKI SAKYO-KU KYOTO-SHI KYOTO 606-8333

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Iwamoto, Masahiro Minoo, JP 44 451
Nakamura, Toshikazu Takatsuki, JP 159 1525
Noji, Sumihare Tokushima, JP 2 17

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation